Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04742153 | A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) | unknown | Phase 2 | 66 | Shanghai Miracogen Inc.INDUSTRY | 1 | Sep 7, 2022 | clinicaltrials |
| NCT05530876 | Tele-rehabilitation in Women With Breast Cancer During COVID-19 Pandemic. | unknown | N/A | 60 | University of Sao PauloOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT04930692 |
| A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients" |
| unknown |
| N/A |
| 31 |
| Saint Petersburg State University, RussiaOTHER |
| 1 |
| Sep 6, 2022 |
| clinicaltrials |
| NCT05186545 | An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer | unknown | Phase 2 | 63 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05512416 | Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer | unknown | Phase 2 | 35 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT05512468 | Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy | unknown | N/A | 200 | Fujian Medical University Union HospitalOTHER | 1 | Aug 23, 2022 | clinicaltrials |
| NCT05501158 | CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population | unknown | N/A | 150 | Nalagenetics Pte LtdINDUSTRY | 1 | Aug 19, 2022 | clinicaltrials |
| NCT03720431 | TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer | unknown | Phase 1 | 11 | PharmAbcineINDUSTRY | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05504213 | A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer | unknown | Phase 1 | 224 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05498311 | Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy(IORT_BREAST) | unknown | Phase 2 | 89 | Institut Català d'OncologiaOTHER | 1 | Aug 15, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT04962529 | Breast Cancer Liquid Biopsy Trial | unknown | — | 450 | Anthony MaglioccoINDUSTRY | 2 | Aug 11, 2022 | clinicaltrials |
| NCT03805399 | FUSCC Refractory TNBC Umbrella (FUTURE)(FUTURE) | unknown | Phase 1 / Phase 2 | 140 | Fudan UniversityOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT05007444 | Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer | unknown | Phase 2 | 58 | Hospital Universitario San IgnacioOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05258526 | Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study)(BENEFIT-CA) | unknown | N/A | 80 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05491057 | Treatment Patterns of Neratinib in HER2+ EBC in China | unknown | — | 500 | Pierre Fabre MedicamentINDUSTRY | 1 | Aug 8, 2022 | clinicaltrials |
| NCT05491694 | To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer(HIFU) | unknown | Phase 2 | 20 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Aug 8, 2022 | clinicaltrials |
| NCT04948983 | The Effect of a Patient Decision Aids for Breast Cancer Screening | unknown | N/A | 3,269 | Pontificia Universidad Catolica de ChileOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05483439 | A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer | unknown | Phase 2 | 100 | Shengjing HospitalOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05486936 | RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | unknown | — | 195 | Ruijin HospitalOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT04429893 | Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy | unknown | Phase 2 / Phase 3 | 80 | Alexandria UniversityOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT04355858 | Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer(MULAN) | unknown | Phase 2 | 319 | Fudan UniversityOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT04297267 | A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy(nonpCR GP) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT05469750 | Dalpiciclib Plus Letrozole and Capecitabine | unknown | Phase 2 | 48 | Fujian Medical University Union HospitalOTHER | 0 | Jul 22, 2022 | clinicaltrials |
| NCT03025139 | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)(PTW) | unknown | N/A | 96 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT05468710 | Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | unknown | — | 150 | Ain Shams UniversityOTHER | 0 | Jul 21, 2022 | clinicaltrials |
| NCT05466760 | PET/MR Radiomics for Breast Cancer Diagnosis | unknown | — | 120 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05461534 | Mindfulness Yoga and Sexual Functioning | unknown | N/A | 78 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jul 18, 2022 | clinicaltrials |
| NCT05461690 | Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 0 | Jul 18, 2022 | clinicaltrials |
| NCT05457309 | Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients | unknown | N/A | 50 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT05444647 | Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study | unknown | — | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 6, 2022 | clinicaltrials |
| NCT05443672 | Multi-center Study of Deep Learning AI in Breast Mass | unknown | — | 1,122 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05441098 | Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology | unknown | — | 1,821 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT00496795 | Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer(DDP) | unknown | Phase 2 | 100 | University of BergenOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT04861220 | Surgical Pre-habilitation in Breast Cancer. | unknown | N/A | 248 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05339113 | Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma | unknown | N/A | 100 | The National Center of Oncology, AzerbaijanOTHER_GOV | 1 | Jun 24, 2022 | clinicaltrials |
| NCT04948840 | Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis(TREM-1) | unknown | N/A | 20 | Centre Francois Baclesse, LuxembourgOTHER | 2 | Jun 23, 2022 | clinicaltrials |
| NCT05429294 | Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038 | unknown | Phase 2 | 209 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT04881929 | Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer | unknown | Phase 2 | 30 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Jun 22, 2022 | clinicaltrials |
| NCT04671498 | Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study | unknown | — | 1,200 | Preferred Medicine, IncINDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05424666 | The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction | unknown | N/A | 20 | Assiut UniversityOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04631835 | Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer | unknown | Phase 1 | 54 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05409248 | Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors | unknown | N/A | 120 | Universidad Antonio de NebrijaOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT04619485 | Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy(LIGHT) | unknown | N/A | 84 | Hospital Clinic of BarcelonaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05400993 | Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC | unknown | Phase 2 | 59 | Shengjing HospitalOTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05403333 | Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 61 | Fudan UniversityOTHER | 0 | Jun 3, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Sep 7, 2022source: clinicaltrials